Navigation Links
China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010
Date:3/5/2010

1, 2009 December 31, March 31, 2009 2009 US$ RMB RMB (in thousands except redemption value and number of shares) ASSETS Current assets Cash and cash equivalents 56,560 386,069 161,406 Accounts receivable, less allowance for doubtful accounts (December 31, 2009: RMB9,251; March 31, 2009: RMB 6,170) 8,361 57,071 49,763 Inventories 843 5,757 6,501 Prepaid expenses and other receivables 1,511 10,312 7,978 Deferred tax assets 476 3,249 1,846 Total current assets 67,751 462,458 227,494 Property, plant and equipment, net 37,553 256,331 236,740 Non-current prepayments and deposits 1,735 11,846 27,184 Non-current accounts receivable, less allowance for doubtful accounts (December 31, 2009: RMB5,390; March 31, 2009: RMB2,223) 24,007 163,872 91,761 Inventories 4,153 28,348 26,069 Intangible asset, net 3,888 26,540 27,268 Available-for-sale equity securities 8,780 59,932 26,242 Deferred reverse recapitalization costs -- -- 33,633 Deferred tax assets 89 609 -- Total assets 147,956 1,009,936 696,391 LIABILITIES Current liabilities Bank loan 6,592 45,000 -- Accounts payable 1,274 8,693 5,128 A
'/>"/>
SOURCE China Cord Blood Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related biology technology :

1. Tianyin Pharmaceutical Co., Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing on March 9
2. China Sky One Medical to Attend Rodman & Renshaw Annual China Investment Conference
3. China Baicaotang to Attend Rodman & Renshaw Annual China Investment Conference
4. China Medical Technologies Reports Third Fiscal Quarter Financial Results
5. Nutrastar International, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing
6. China-Biotics, Inc. Appointed Grayling as Strategic Investor Relations Advisor
7. China-Biotics, Inc. Inaugurated the Commercial Production of its New Production Facility
8. China Sky One Medical Confirms Continued Sale of Seven of Eight Products on the Ministry of Healths Warning List
9. China-Biotics, Inc. Reports Third Quarter Fiscal 2010 Financial Results
10. China Medical Technologies to Participate Investor Conferences in March 2010
11. China Biologic Products Responds to Allegations on Financial Websites
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 30, 2015 Sanofi, un ... ses résultats pour le premier semestre 2015. Le ... résultats. Visionner l,interview vidéo et lire ... Au sommaire de l,interview :  ... de croissance - Diabète ...
(Date:7/29/2015)... July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... Company,s Chief Financial Officer has resigned.  The Company has ... Officer who retired in December 2014, as full time ... permanent successor.     Andy Ashworth began ... ensure a smooth transition.  Andy was the Company,s CFO ...
(Date:7/29/2015)... DUBLIN , July 29, 2015 ... ) has announced the addition of the ... to their offering. The Global Biosimilars ... study of the rapidly growing biosimilars market. With ... industry striving to minimize costs, biosimilars are being ...
(Date:7/29/2015)... July 29, 2015  Pfenex Inc. (NYSE MKT: PFNX) ... will be released on Thursday, August 13, 2015, before ... Pfenex management will host a conference call to discuss ... press release outlining the financial results and business update ... Please call 1-866-376-8058 (US) or 1-412-542-4131 (international) and ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2
... COLUMBIA, Md., Dec. 13 Martek Biosciences,Corporation announced ... DHA and,ARA license and supply agreement for infant ... Pharmaceutical. Under the terms of the,agreement, Martek will ... IlDong,Foodis infant formula products in South Korea., ...
... the US Oncology Adjuvant Trial 9735 at 2007 ... and Cyclophosphamide Improved Overall ... Dec. 13 Results presented at the,30th annual ... for,women with early stage breast cancer who have ...
... diseases for this collaboration are Diffuse Large Cell Lymphoma, Transformed Follicular Lymphoma, and Chronic ... ... cancers in 2007 in ... US alone(1), -- MicroRNAs hold significant potential as highly sensitive and specific ...
Cached Biology Technology:Martek Signs DHA/ARA License and Supply Agreement With IlDong Foodis for Infant Formula in South Korea 2Martek Signs DHA/ARA License and Supply Agreement With IlDong Foodis for Infant Formula in South Korea 3Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 2Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 3Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 4Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 5Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma 2Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma 3Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma 4Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma 5
(Date:6/25/2015)... 25, 2015  Imagine a tool specifically designed to ... happier life. That,s exactly what USANA,s True Health ... cutting-edge, portable health program provides a personalized approached to ... improve your lifestyle and nutrition. At ... Wednesday night, USANA,s THA was honored with the Industry ...
(Date:6/24/2015)... June 24, 2015 The biologics safety testing ... drivers for the market include growth of the pharmaceutical ... drug launches. Over the years, the number of drug ... and 2010, the FDA approved 225 drug applications and ... Europe accounted for 3,822 of ...
(Date:6/24/2015)... Calif. , June 24, 2015  Synaptics ... of human interface solutions, today announced that Sharp ... to provide secure authentication for its latest flagship ... reached more than 200 million shipments of its ... Sharp reinforces Synaptics, strength, scalability and leadership in ...
Breaking Biology News(10 mins):@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2
... will address the 31st annual Western Apicultural Society (WAS) ... The main conference sessions will take place in the ... Creek Road. "The conference provides an ... and to interact with professionals," said president Eric Mussen ...
... natural climate archives. For the temperate latitudes it ... depend mainly on temperature and precipitation. In the ... correlation is not so evident. Now scientists of the ... of the Australian National University have been able to ...
... What dog owner has not come home to a broken ... around the house? By ingeniously setting up conditions where the ... committed an offense, Alexandra Horowitz, Assistant Professor from Barnard College ... in dogs in the recently published "Canine Behaviour and Cognition" ...
Cached Biology News:'Honey bee health' of concern at Western Apicultural Society conference 2'Honey bee health' of concern at Western Apicultural Society conference 3Australia's climate: Drought and flooding in annual rings of tropical trees 2What really prompts the dog's 'guilty look' 2
... BODIPY FL ATP-Gamma-S binds to ATP-binding ... the BODIPY FL fluorophore was linked ... addition to its potential use for ... thioether is an important new substrate ...
... Using information-rich MSn data, the patent-pending ... multiple levels of fragmentation, isotope pattern ... to accurately determine the correct formula ... approaches for deducing empirical formulae from ...
... peptide synthesis with a wide variety of purity ... research needs. Purity: IG(>50%), >70%, ... Sequence Length: Up to 120 ... C-amidation, phosphorylation, D-amino acids, MAPs, KLH/BSA conjugation, and ...
... pyruvate, 50 mg/L streptomycin sulfate, 100 mg/L ... and magnesium chloride. The use of a ... is generally attributed to early workers in ... a solution of inorganic salts designed to ...
Biology Products: